Target Details
| UniProt AC | P12931 |
|---|---|
| Gene Symbol | SRC |
| Protein Name | Proto-oncogene tyrosine-protein kinase Src |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF07714 (PK_Tyr_Ser-Thr) PF00017 (SH2) PF00018 (SH3_1) |
Summary
- Multi-target molecules 1,978
- Clinical molecules 816
- Avg pChEMBL 7.32
KEGG Pathways (45)
- Adherens junction
- Axon guidance
- Bacterial invasion of epithelial cells
- Bladder cancer
- C-type lectin receptor signaling pathway
- Chemical carcinogenesis - reactive oxygen species
- Chemical carcinogenesis - receptor activation
- Chemokine signaling pathway
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Endocytosis
- Epithelial cell signaling in Helicobacter pylori infection
- ErbB signaling pathway
- Estrogen signaling pathway
- Fluid shear stress and atherosclerosis
- Focal adhesion
- GABAergic synapse
- Gap junction
- GnRH signaling pathway
- Hepatitis B
- Herpes simplex virus 1 infection
- Hormone signaling
- Human cytomegalovirus infection
- IgSF CAM signaling
- Inflammatory mediator regulation of TRP channels
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Mitophagy - animal
- Neutrophil extracellular trap formation
- Oxytocin signaling pathway
- Pathogenic Escherichia coli infection
- Platelet activation
- Prolactin signaling pathway
- Proteoglycans in cancer
- Rap1 signaling pathway
- Regulation of actin cytoskeleton
- Relaxin signaling pathway
- Shigellosis
- Thyroid hormone signaling pathway
- Tight junction
- Tuberculosis
- VEGF signaling pathway
- Viral carcinogenesis
- Yersinia infection
Associated Diseases (2)
Active Molecules (1,978)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
ZPKIWFITUKOGJS
|
8.0 | IC50 | 3 | — | |
ZQADJVAMOQTKDB
|
8.0 | IC50 | 3 | — | |
RMUPVRXJXNJUAA
|
8.0 | IC50 | 2 | — | |
BSJIKWAUGXTMRQ
|
8.0 | IC50 | 2 | — | |
GIEDBGFYGHINFT
|
8.0 | IC50 | 8 | — | |
BLYRPGBSIKAIAU
|
8.0 | IC50 | 24 | Yes | |
CGELEDQBCPRRSA
|
8.0 | IC50 | 3 | — | |
DHSZWTFDQUUKJT
|
8.0 | IC50 | 3 | — | |
DJZYNWPPCYQNDL
|
8.0 | IC50 | 2 | Yes | |
GVDMYBWNSNCDMN
|
8.0 | IC50 | 3 | Yes | |
JXDYOSVKVSQGJM
|
8.0 | IC50 | 7 | — | |
KADSTJJZALTROR
|
8.0 | IC50 | 4 | — | |
KOHAPQKJEAQWMF
|
8.0 | IC50 | 3 | — | |
KWEVSNRXKHUTLB
|
8.0 | IC50 | 3 | — | |
LVUGPVDXTSJQQD
|
8.0 | IC50 | 13 | Yes | |
MPYUMMWCLQVMLG
|
8.0 | IC50 | 11 | — | |
OHTDBFPGRCKSTH
|
8.0 | IC50 | 2 | — | |
OTTCBLPTHPBEEX
|
8.0 | IC50 | 11 | Yes | |
PNYZVGKTHJXNGD
|
8.0 | IC50 | 4 | — | |
QHHCOZDURKDLDL
|
8.0 | IC50 | 3 | — | |
VEORWCZDRQSGJH
|
8.0 | IC50 | 10 | Yes | |
VFRGUPCPOYDATL
|
8.0 | IC50 | 3 | — | |
WAIFVHBFMAMLSV
|
8.0 | IC50 | 3 | — | |
WHKSAKSSQHTIKP
|
8.0 | IC50 | 4 | — | |
WWSVFJIFHQKQLY
|
8.0 | IC50 | 3 | — | |
XTMQXGYZVJVLMD
|
8.0 | IC50 | 3 | Yes | |
ZCIMSJOHBOGKMX
|
8.0 | IC50 | 3 | — | |
ZHBTZVAVYLOIKW
|
8.0 | IC50 | 11 | Yes | |
ZJWVUNKNOQBTOR
|
8.0 | IC50 | 4 | — | |
QNWAZYDNHYUGCX
|
7.9 | IC50 | 2 | — | |
VPAAYYSCJUHANG
|
7.9 | IC50 | 2 | Yes | |
XXSPPIWQGKTKEQ
|
7.9 | IC50 | 3 | — | |
AMUSCCPWKQVJSJ
|
7.9 | IC50 | 4 | — | |
CEUSZLVORFRBCV
|
7.9 | IC50 | 13 | — | |
CYKJKKJPMBDBAT
|
7.9 | IC50 | 4 | — | |
DAZNPHVDUSTLGK
|
7.9 | IC50 | 4 | — | |
DCAMTYGKRNMTNB
|
7.9 | IC50 | 2 | — | |
GZOONDJISKPFEJ
|
7.9 | IC50 | 4 | — | |
KYCKVFRIBMZEAX
|
7.9 | IC50 | 2 | — | |
LSALXSOZDWYUQQ
|
7.9 | IC50 | 3 | — | |
MKJKFFODUSDVSK
|
7.9 | IC50 | 3 | — | |
ONXVBFWIQSGWAH
|
7.9 | IC50 | 2 | — | |
PDRRMIHGJSJJLS
|
7.9 | IC50 | 3 | — | |
PKNCVDHZYUZNRB
|
7.9 | IC50 | 3 | — | |
SBGKNONFYWLESF
|
7.9 | IC50 | 3 | — | |
URQAXVPGUSETSW
|
7.9 | IC50 | 4 | — | |
VFQNGIVBLUWECA
|
7.9 | IC50 | 4 | — | |
VREZKFPACUPTJS
|
7.9 | IC50 | 5 | — | |
WIAJWJSFVQRBAD
|
7.9 | IC50 | 3 | — | |
XCEDFZFYFQZOMX
|
7.9 | IC50 | 3 | Yes |